Cost-Effectiveness Analysis of Adalimumab Versus Cyclosporine for Vogt-Koyanagi-Harada Disease: A Randomized Controlled Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-Effectiveness Analysis of Adalimumab Versus Cyclosporine for Vogt-Koyanagi-Harada Disease: A Randomized Controlled Study

Published:2024-05-23 Issue:10 Volume:49 Page:1080-1088
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Dai Lingyu¹,Zhong Zhenyu¹,Wu Qiuying¹,Gao Yu¹,Lu Xiaorong¹,Zhang Fuxiang¹,Tang Chong¹,Wang Yao¹,Zhou Chunjiang¹,Yang Peizeng¹

Affiliation:

1. The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, People’s Republic of China

Funder

National Natural Science Foundation of China Major International (Regional) Joint Research Project

National Natural Science Foundation of China Key Program

Chongqing Key Laboratory of Ophthalmology

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2024.2355659

Reference34 articles.

1. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment

2. Clinical Characteristics of Vogt–Koyanagi–Harada Syndrome in Chinese Patients

3. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease

4. Visual Functioning and Health-related Quality-of-Life are Compromised in Patients with Uveitis

5. Quality of Life in Patients with Uveitis on Chronic Systemic Immunosuppressive Treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP